These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4898530)

  • 1. Laboratory and clinical evaluation of carbenicillin (carboxybenzyl penicillin).
    Silverblatt F; Turck M
    Antimicrob Agents Chemother (Bethesda); 1968; 8():279-85. PubMed ID: 4898530
    [No Abstract]   [Full Text] [Related]  

  • 2. BL-P 1654, a new broad-spectrum penicillin with marked antipseudomonal activity.
    Price KE; Leitner F; Misiek M; Chisholm DR; Pursiano TA
    Antimicrob Agents Chemother (Bethesda); 1970; 10():17-29. PubMed ID: 5000254
    [No Abstract]   [Full Text] [Related]  

  • 3. [Laboratory and clinical evaluation on carbenicillin].
    Kiriyama T; Sakatoku J
    Hinyokika Kiyo; 1970 Nov; 16(11):683-7. PubMed ID: 5530621
    [No Abstract]   [Full Text] [Related]  

  • 4. Human pharmacology and clinical evaluation of an oral carbenicillin preparation.
    Bran JL; Karl DM; Kaye D
    Clin Pharmacol Ther; 1971; 12(3):525-30. PubMed ID: 5208911
    [No Abstract]   [Full Text] [Related]  

  • 5. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
    Quentin C; Sageaux JC; Bebear C; Latrille J
    Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity of a new semisynthetic penicillin derivative: piperacillin. Clinical and experimental research].
    Romeo R; Sorace R; Libertini C; Santangelo C; Patanè S; Di Stefano F; Gatto A
    G Ital Chemioter; 1981; 28(1-2):61-4. PubMed ID: 6751918
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences in treatment of Pyocyaneus infections of the urinary tract by carbenicillin].
    Gritz K; Naumann P
    Arzneimittelforschung; 1969 Aug; 19(8):1237-41. PubMed ID: 4980238
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro susceptibility and resistance of gram negative bacilli to carbenicillin.
    Athar MA
    Hindustan Antibiot Bull; 1970; 13(1):1-7. PubMed ID: 4993698
    [No Abstract]   [Full Text] [Related]  

  • 9. [Amoxycillin. Bacteriologic, pharmacologic, and clinical data].
    Vandepitte J
    Poumon Coeur; 1973; 29(4):465-9. PubMed ID: 4603179
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory and clinical studies of carbenicillin against gram-negative bacilli.
    Standiford HC; Kind AC; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1968; 8():286-91. PubMed ID: 5735373
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacteriological, pharmacological, and clinical studies of carbenicillin.
    Meyers BR; Sabbaj J; Weinstein L
    Arch Intern Med; 1970 Feb; 125(2):282-6. PubMed ID: 4983746
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of amoxycillin--a new semisynthetic penicillin.
    Sabto J; Carson P; Morgan T
    Med J Aust; 1973 Sep; 2(11):537-41. PubMed ID: 4748581
    [No Abstract]   [Full Text] [Related]  

  • 13. Piperacillin and carbenicillin; a collaborative in vitro comparison against 10,838 clinical bacterial isolates.
    Jones RN; Fuchs PC; Gerlach EH; Gavan TL
    Cleve Clin Q; 1979; 46(2):49-55. PubMed ID: 256523
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of gentamicin with carbenicillin in infections due to gram-negative bacilli.
    Klastersky J; Cappel R; Debusscher L
    Curr Ther Res Clin Exp; 1971 Mar; 13(3):174-81. PubMed ID: 4998289
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transmissible resistance toward polysynthetic penicillins].
    Datta N
    Antibiotiki; 1971 Jun; 16(6):523-5. PubMed ID: 5000147
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effective treatment of urinary tract infection with carbenicillin].
    Yamamoto C; Miyoshi T; Namikawa K; Fukuchi S
    Hinyokika Kiyo; 1971 Sep; 17(9):596-600. PubMed ID: 5001081
    [No Abstract]   [Full Text] [Related]  

  • 17. Temocillin susceptibility by BSAC methodology.
    Andrews JM; Jevons G; Walker R; Ashby J; Fraise AP
    J Antimicrob Chemother; 2007 Jul; 60(1):185-7. PubMed ID: 17550891
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of mezlocillin and carbenicillin as therapy for various infectious diseases.
    Rolandi E; Barreca T; Ragni N; Valente U; Sannia A; Fontana I; Magnani G; Salvini P
    Clin Ther; 1981; 4(4):321-5. PubMed ID: 6460558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carbenicillin. Current data on its use].
    Bertoye A; Woehrle R
    Lyon Med; 1971; 225():Suppl:137-41. PubMed ID: 5564793
    [No Abstract]   [Full Text] [Related]  

  • 20. Emergence of resistance in Pseudomonas during carbenicillin therapy.
    Holmes KK; Clark H; Silverblatt F; Turck M
    Antimicrob Agents Chemother (Bethesda); 1969; 9():391-7. PubMed ID: 5202411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.